Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

OBJECTIVES: To evaluate the relationship between bone mineral density (BMD) and biomarkers of bone turnover and inflammation in patients with ankylosing spondylitis (AS) treated with infliximab. METHODS: Patients (n = 279) were randomly assigned (3:8) to receive placebo or 5 mg/kg infliximab every 6...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Visvanathan, S, van der Heijde, D, Deodhar, A, Wagner, C, Baker, D G, Han, J, Braun, J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2008
Konular:
Clinical and Epidemiological Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605572/
https://ncbi.nlm.nih.gov/pubmed/18495735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.084426
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller